User profiles for Milan Grkovski
Milan GrkovskiAssistant Attending Physicist, Memorial Sloan Kettering Cancer Center Verified email at mskcc.org Cited by 791 |
Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial
…, X Pei, H Schöder, M Grkovski… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Patients with human papillomavirus–related oropharyngeal cancers have
excellent outcomes but experience clinically significant toxicities when treated with standard …
excellent outcomes but experience clinically significant toxicities when treated with standard …
[HTML][HTML] B7H3-directed intraperitoneal radioimmunotherapy with radioiodinated omburtamab for desmoplastic small round cell tumor and other peritoneal tumors …
S Modak, P Zanzonico, M Grkovski… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
PURPOSE Desmoplastic small round cell tumor (DSRCT), a rare sarcoma of adolescents/young
adults primarily involving the peritoneum, has a long-term survival of< 20% despite …
adults primarily involving the peritoneum, has a long-term survival of< 20% despite …
Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer
Purpose: We performed a first-in-human clinical trial. The aim of this study was to determine
safety and feasibility of PET imaging with 18 F-PARPi in patients with head and neck cancer. …
safety and feasibility of PET imaging with 18 F-PARPi in patients with head and neck cancer. …
Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-Fluorodeoxyglucose positron emission tomography radiomics …
Background and purpose Hypoxia is a known prognostic factor in head and neck cancer.
Hypoxia imaging PET radiotracers such as 18 F-FMISO are promising but not widely available. …
Hypoxia imaging PET radiotracers such as 18 F-FMISO are promising but not widely available. …
Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics
In this study, we investigate the use of imaging feature-based outcomes research ('radiomics')
combined with machine learning techniques to develop robust predictive models for the …
combined with machine learning techniques to develop robust predictive models for the …
[HTML][HTML] Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system
…, A Ku, T Kalidindi, SG Lee, M Grkovski… - Nature …, 2021 - nature.com
Diseases are a manifestation of how thousands of proteins interact. In several diseases,
such as cancer and Alzheimer’s disease, proteome-wide disturbances in protein-protein …
such as cancer and Alzheimer’s disease, proteome-wide disturbances in protein-protein …
Multiparametric imaging of tumor hypoxia and perfusion with 18F-fluoromisonidazole dynamic PET in head and neck cancer
Tumor hypoxia and perfusion are independent prognostic indicators of patient outcome. We
developed the methodology for and investigated the utility of multiparametric imaging of …
developed the methodology for and investigated the utility of multiparametric imaging of …
Biodistribution and dosimetry of intraventricularly administered 124I-omburtamab in patients with metastatic leptomeningeal tumors
…, PB Zanzonico, K Kramer, M Grkovski… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Radiation dose estimations are key for optimizing therapies. We studied the role of 124 I-omburtamab
(8H9) given intraventricularly in assessing the distribution and radiation doses …
(8H9) given intraventricularly in assessing the distribution and radiation doses …
Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer
Purpose There is growing recognition that biologic features of the tumor microenvironment
affect the response to cancer therapies and the outcome of cancer patients. In head and neck …
affect the response to cancer therapies and the outcome of cancer patients. In head and neck …
[PDF][PDF] Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatment
Background Brain cancer incidence and mortality rates are greater in males. Understanding
the molecular mechanisms that underlie those sex differences could improve treatment …
the molecular mechanisms that underlie those sex differences could improve treatment …